www.ghp-news.com Featuring: Australian biotech Skin Elements heads to the UK Skin Elements is an award-winning, publicly listed (ASX: SKN) natural formulation company based in Australia, with the mission of improving the health and wellness of people across the globe, without harming the planet. With research underpinning its fundamental purpose over more than two decades of operation, the company is now commencing the commercialisation into the UK market with its revolutionary Soléo Organics sunscreen. Recognised as our Best Natural Sunscreen Brand 2024 – Australia, we speak to Executive Chairman and CEO Peter Malone to discover what makes its products stand out entirely from the rest. Q2 2024
Welcome to the Q2 2024 edition of Global Health & Pharma magazine, providing you with all the latest news and features across the healthcare and pharmaceutical landscape. Q2 2024 This quarter, we are excited to be featuring environmentally friendly, vegan skincare formulation company, Skin Elements as our Best Natural Sunscreen Brand 2024 – Australia. With exciting plans on the horizon for the company to bring its award-winning Soléo Organics sunscreen range to the UK, we speak to Director, Peter Malone to discover the brilliant work that goes into creating such groundbreaking formulations and what exactly makes Skin Elements the award-winning brand it is. From there, we explore a variety of exceptional organisations with specialist offerings ranging from CBD pet products, mental health care, IVF and fertility, disability support, beauty aesthetics, sexual rejuvenation, and many, many more. Each of these organisations has proven themselves to be true experts in their fields, delivering next-level products and services that are truly changing lives for the better. We hope you find this issue to be informative and inspiring, and we look forward to welcoming you back again soon for our Q3 issue. Rebecca Scotland, Editor Website: www.ghp-news.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.
Subscribe to GHP www.ghp-news.com/subscribe
Contents 6. News 8. Australian biotech Skin Elements heads to the UK 12. Purity Hemp Company: Best Pet CBD Products Brand - UK 13. Transforming Cancer Healthcare 14. Allife Medicine: Best iPSC & iPSC-CAR-NK Cell Development Company 2024 & GHP Innovation Excellence Award 2024 16. Abbey House Dental: Best Dental Practice - Staffordshire 17. Intrinseque Health: Best Clinical Supply Chain Solutions Provider 2024 - Singapore 18. Chaperoned Istanbul Hair Transplant Services 19. Care Solace: Most Innovative Mental Health Solution 2024 California & GHP Client Inclusivity Award 2024 20. Pioneering IVF and Fertility Treatment 21. Transformative Aesthetic Results 22. Everyone Health: Best Community Health Company 2024 - East Midlands 23. Enhance Your Natural Beauty 24. First Thought Care Services: Most Trusted Disability Support Organisation 2024 – Gloucestershire & GHP Employee Excellence Awards 2024 26. The Future of Drug Delivery 27. Hyaluronic Acid Reimagined 28. Aamira Home Care: Most Trusted Family-Owned Home Care Agency 2024 - Maryland 29. Fortifying the World of Diagnostics 30. Homecare Team Ltd: Most Compassionate Home Care Provider 2024 - Greater Manchester 32. Bettering Care and Improving Lives 33. Dynamic Duo Delivering Trusted Treatments 34. Beautifully Balanced Aesthetic Results 35. Harwood Child Psychology: Best Specialist Child Psychology Service 2024 - London 36. Biopharmaceutical Pioneer Develops Industry Leading Platform Technology 38. The Godfather of Sexual Rejuvenation 39. Yvonne Hayward: Wellbeing Therapist of the Year 2024 (Cologne) 40. Treating the Venous Conditions that Plague Millions 42. Rhinoplasty London by East and Badia: Best Rhinoplasty Clinic 2024 – London 43. Changing Aesthetics, One Treatment at a Time 44. Integrated Care, Exceptional Outcomes 45. Bringing Laboratories into the Future 46. Ai Beauty: Unparalleled Aesthetics, Outstanding Care 48. Getting the Planet Out of its Pickle 49. Potomac Psychiatry: Comprehensive Mental Health Center of the Year 2024 – Mid-Atlantic USA 50. Amazing Anti-Ageing Abilities 51. Attain Premier Veins with Industry Experts 52. Algalif: Best Natural Astaxanthin Products Supplier 2024 & GHP Innovation Excellence Award 2024
NEWS Rockinghorse Children’s Charity is working with the Royal Alexandra Children’s Hospital and Brighton and Sussex Medical School to expand access to the world’s first clinic to treat childhood asthma using innovative precision medicine approaches. More than 1.1 million children in the UK are currently receiving treatment for asthma. The condition is usually treated with inhalers, but until recently, this has been generally untargeted, with similar approaches being used regardless of the child’s individual characteristics or environment. This ‘one size fits all’ approach may mean that some children don’t respond to treatments in the most effective way. When this happens, it can be difficult to know why the same treatments do not work in the same way for every child. However, this research has found that there are ways to help target the exact type of treatment that’s right for each individual child. Rockinghorse Children’s Charity has previously funded some initial research by Professor Somnath Mukhopadhyay and his team at Brighton and Sussex Medical Rockinghorse Children’s Charity is expanding access to the world’s first clinic for treating childhood asthma using innovative precision medicine approaches. School, which developed the personalised approach to treatment based on the genotype of the individual child. This led to the development of a specialist pilot clinic at the Royal Alexandra Children’s Hospital, using this approach to find the best way to treat children with asthma. Professor Mukhopadhyay said, “Rockinghorse’s funding has been very important in supporting the first ever role out of a personalised medicine led clinic in children’s asthma. We hope this will lead to information that can encourage the NHS to consider adopting these practices nationwide.” Testing a child to determine their genetic makeup can reveal what medications won’t work for them and, crucially, the ones that will. This means that each child has a better chance of receiving more appropriate treatments for their condition. This work has resulted in interest at the national level. The NHS is currently discussing how we can study costeffectiveness, with the aim of making these treatments accessible for children more widely across the UK. Anyone who has experienced asthma, whether as an adult or a child, will understand the impact it can have on many aspects of life. It can stop them from playing sports, having a pet, or even doing simple things like walking to school or climbing the stairs. These new treatments for severely affected children have proved life-changing. One child who previously struggled with controlling his asthma reported his breathing capacity to have transformed virtually overnight after receiving genotype-directed personalised treatment. Similar improvements have also been reported by other children receiving personalised care. The research has also been used to create a shift in awareness of these new treatment options. This is now improving clinical practice, informing General Practitioner training in the UK, and is formalised within international treatment guidelines in Australia. However, despite the success of this initial work, the option to receive personalised
• On 25th May, 50 tradespeople played a charity football tournament at Chelsea’s Stamford Bridge stadium • The event aimed to raise awareness of the benefits of exercise on mental health • ‘Other Trades’ were crowned the overall champions, winning on penalties On Saturday 25th May, 50 tradespeople competed at Chelsea’s Stamford Bridge stadium in the first ever Match for the Mind, organised by IronmongeryDirect, and the event raised over £4,000 for the mental health charity Mind. The six teams were each made up of representatives of different trades, and the tournament was eventually won by the Other Trades after beating the Electricians on penalties in the final. After finishing 1-1 in normal time, the Other Trades triumphed 7-6 in the shootout. Bobby Funnell, playing for the Electricians received the Golden Boot award for being the top goalscorer overall, having scored five, and was presented with a golden work boot. All players received an engraved medal. Players were required to donate to Mind ahead of the day, and these sums were then added to the totals raised at the stadium through additional fundraising activities, such as a penalty shootout and crossbar challenge, where IronmongeryDirect gave £10 to charity for each successful effort. In total, Match for the Mind donated over £4,000 to Mind, helping to support their vital services. The event was attended by players’ friends, family and colleagues, as well as three famous football freestylers, including Andrew Henderson, the five-time world champion. A representative from Basildon Mind also attended the tournament to share mental health advice with both the players and spectators. The contest at Stamford Bridge was organised in line with the ‘movement’ theme of this year’s Mental Health Awareness Week and aimed to raise awareness of the benefits of exercise on mental wellbeing. IronmongeryDirect’s annual Mental Health in the Trades report recently found that more than four in five (82%) UK tradespeople experience some form of mental health issue due to work. Jay Mccrindle (pictured), a 29-year-old plumber who played in the tournament, shared his mental health experience: “My father died by suicide at the age of 14. I have always been plagued with mental health issues. I have been confused and unsure since losing my father. However, with the guidance of Mind and my family, I have now accepted what happened. I am thrilled to have had the opportunity to combine my two passions of mental health awareness and Chelsea by playing in Match for the Mind.” Andrew Berrie, Head of Corporate Partnerships at Mind, discusses the benefits of staying active on people’s mental wellbeing: “We are so grateful to IronmongeryDirect for choosing to fundraise for Mind and helping us highlight how exercise can benefit our mental health. “Exercise has long been proved to have a positive effect on the mental health of millions. We want to help more people make moves for their mental health as this can help to manage stress and improve your sleep, mood and confidence. “We’re in the middle of a mental health crisis, with over two million people waiting for NHS mental health services. Now more than ever it is vital that everyone has access to the right support, advice and information when they need it. “The money raised by IronmongeryDirect will help Mind raise both awareness and vital funds so that we can move closer to a future where no mind is left behind.” Ellis Osborn, Ecommerce Manager at IronmongeryDirect, said: “We’re thrilled that everyone had such a good day at our inaugural Match for the Mind, and that we were able to raise so much money for charity. And the Other Trades now have the bragging rights! “Thank you to everyone who donated, took part or supported the brilliant tradespeople who played. Mental health problems are unfortunately prevalent across the industry, and that’s why we’re continuing to raise awareness, and encourage people to seek support if needed.” Ironmongery Direct’s Match for the Mind raises £4,000 for mental health charities medicine treatments remains widely unknown to patients, the public, and other medical practitioners outside of these clinics. The next stage of this work’s work is based on spreading the word about these new treatments. This aims to raise public awareness and encourage patient engagement so that more children and families can benefit from this transformative research. Donna Holland, Rockinghorse CEO, said, “Asthma can have a profound impact on a child, stopping them from enjoying so many of the things that children enjoy. It can mean avoiding pets and other animals, finding sport challenging and suffering from allergic reactions to something as simple as cut grass or flowers. “But with more access to this cuttingedge Precision medicine treatment, children with asthma will be better supported, and they, and their families, will have access to better, more effective care, support and treatment. “We are so proud to be able to lead the way with this world-class clinic in Sussex. Rockinghorse Children’s Charity has a long-standing involvement and support of precision medicine research and its implementation for asthma and allergies at the “Alexandra Children’s Hospital in Brighton. This game-changing project expands the support and services available to children and young people with asthma all over Sussex.”
8 May24328 Skin Elements is an award-winning, publicly listed (ASX: SKN) natural formulation company based in Australia, with the mission of improving the health and wellness of people across the globe, without harming the planet. With research underpinning its fundamental purpose over more than two decades of operation, the company is now commencing the commercialisation into the UK market with its revolutionary Soléo Organics sunscreen. Recognised as our Best Natural Sunscreen Brand 2024 – Australia, we speak to Executive Chairman and CEO Peter Malone to discover what makes its products stand out entirely from the rest. Australian-made. Cruelty-free. Vegan. Reef-friendly. Biodegradable. Organic-certified. These are the principles behind everything that Skin Elements does. Having seen a gap in the market for natural alternatives to chemical sunscreens and face creams, Skin Elements noticed how, in recent years, and particularly since the pandemic, there has been a growing awareness and interest in maintaining a healthy lifestyle and a healthy planet. There is increasing evidence, knowledge, and awareness of the effects of harmful, aggressive toxic ingredients on our bodies, livestock, crops, land, and waterways. Peter Malone cites, “What used to be only a focus for ultrahealthy people has gone mainstream. It is completely normal now for consumers to want to know what ingredients are in the products they use on themselves and their families, so they can buy products that aren’t harmful. This topic has gone from a private conversation amongst a minority of people to a public conversation that crosses demographics and geographies. “More and more informed and climate-conscious consumers and businesses are demanding eco-friendly and biodegradable solutions with improved efficacy and performance properties, and in our view this demand for alternatives to chemical-based products are not being taken seriously by the large global companies.” With this in mind, Skin Elements set about crafting formulations that meet these evolving expectations. Keeping R&D at its core, the company’s products use an advanced evidencebased process for creating natural formulae. It all began when Peter Malone, a successful entrepreneur met Leo Fung, who was researching into sunscreens using only natural organic ingredients that resulted in the foundation of Skin Elements. The hard work commenced leading to the invention of the innovative proprietary anti-microbial SE Formula™ biotechnology. The SE Formula™ has gone on to form the base of every natural product created by Skin Elements, with each formulation being scientifically proven and independently verified for high performance, using only natural, plant-based ingredients, and completely leaving out the synthetic chemicals and substances. With this groundbreaking approach, the company can formulate products that are safer, more effective, and longer lasting than any competitor. “We have already spent almost 20 years developing and refining our formula and this is a material advantage for us over the rest of the industry because we will be first to market with this innovation. Even with their much greater access to capital for substantial R&D investment, you can’t rush product development and testing if you want to do it properly, so they are years away from catching up to us.” Australian biotech Skin Elements heads to the UK
GHP Q2 2024 As an R&D company, Skin Elements knows that it is its people who bring its purpose-led business strategy and culture to life, with Peter saying, “It is very fulfilling for all of us to come to work every day knowing we are creating products that are healthy for people and the environment. This purpose is something we are very passionate about and proud to be a part of.” At the foundation of this are values of ‘Sustainability’, ‘Quality’, ‘Innovation’, ‘Integrity’, ‘Health and Wellness’, and ‘Collaboration’, all of which are highly reflective of its team’s commitment to creating products that are quality, safe, and support peoples’ health and wellbeing. In terms of ‘Sustainability’, the team remain committed to sustainable practices that protect and preserve the planet. From responsibly sourcing organic ingredients and not testing on animals to minimising the company’s environmental footprint, the team ensure that their processes and products contribute to a healthier world. Having healthy sustainable business operations is integral to the way the organisation operates, its values, and its mission. This approach is made possible through three key areas across the company: responsible sourcing and testing; environmental stewardship; and recyclability and biodegradability. “Our sunscreens are reef-safe, and our packing is all recyclable; even our consumables such as tape and packing peanuts are made from biodegradable substances like cornstarch,” Peter tells us. “We consider ecological impacts when designing and manufacturing our products. Our packaging is 100% recyclable, and our formulae are biodegradable, developed to have no negative impact on the environment, even when in landfill.” ‘Quality’ is an extremely important factor to Skin Elements, too. Excellence remains at the heart of everything it does, with it rigorously testing every product to make sure they meet the highest possible standards of quality and safety, and provides customers with the best natural health and wellness solutions. This comes alongside ‘Innovation’, believing in its power to drive progress within the industry. The team are continually exploring new scientific advancements and technologies to develop cuttingedge products that are truly industry leading. The company also conducts all of its business with ‘Integrity’, guaranteeing honesty and transparency in everything it does. Building trust with its customers, partners, and stakeholders is paramount to Skin Elements, and it upholds the highest ethical standards. Also key among its values is ‘Health and Wellness’, being dedicated to enhancing the wellbeing of its customers. It creates products that promote a healthy lifestyle and empower individuals to achieve their wellness goals naturally. Lastly, ‘Collaboration’ is an important factor in making Skin Elements’ mission a reality, with it valuing partnerships and working closely as a team and with external partners. By working together and sharing knowledge, the Skin Elements team is able to achieve greater outcomes and drive collective success. “We are the only formulation company which is dedicated to developing 100% natural health care alternatives to mass-market chemical-based products. This is the reason for our existence and is what has driven us every day for almost 20 years.” Talking more about what makes Skin Elements stand out in its space, Peter tells us how some large pharma or research companies only dabble in it, producing a variety of ‘natural’ products but using synthetic chemicals to enable product preservation. While some companies are in fact responding to the market’s desire for natural products, Peter says “the major players still have their heads in the sand”, adding, “Well, why wouldn’t they, when they have the market covered with cheap, easy to produce chemical products? But, in our view, this had to change because consumers are demanding
10 it, and that demand wave is turning into a tsunami!” This is what makes Skin Elements different. Thus, from the outset, in the creation of its products, Skin Elements has maintained the implementation of its three-phase strategy, rigorously researching, accrediting, testing, and refining its formulations to create products that are superior and ready for global commercialisation. The use of its SE Formula™ is phase one of the process, enabling the team to develop an all-natural formula that meets the needs of the desired field and purpose, whether suncare or skincare. Indeed, the SE Formula™ phase of the development process focuses on science-led investigations into natural ingredients and processes to prepare prototype formulations. It is here that the team establish robust processes to ensure manufacturing, storage, and distribution timeframes of the product formula to support efficacy, quality, and lifespan. Once the formula has been developed, phase two can begin, where the team complete regulatory approvals, certifications, and closed-group consumer testing pilots. This is a very thorough stage which takes may years of commitment by the company’s R&D experts, performing multiple product laboratory trials, closedgroup consumer testing pilots, and iterative formula enhancement to gain regulatory approvals and certifications. Once these phases are complete, Skin Elements can produce test batches and undertake consumer test marketing in its main target market, with this leading to continued product enhancement until the formulation process is finished. Finally comes the third phase. With an approved and tested product and test marketing complete, the product is ready to launch into distribution, where the company seeks large scale manufacturing or distribution agreements. This is the stage that it has reached with its first formulation, the flagship Soléo Organics, for which development began in 2001. The process of creating Soléo Organics certainly came with its challenges in order to become the first sunscreen globally to use plant-based ingredients and no chemical preservatives. It required multiple ingredient sources, formulations, and manufacturing processes that were evaluated over the period of seven years before the product was ready for market testing. Now, Soléo Organics has solidified its position as the best UV radiation protection product on the market, and the range has expanded to include sunscreens that meet different requirements for different activities, including high water resistance, feather light texture for everyday use, anti-ageing formula for the face, and highly sensitive ingredients for babies. “The fundamental purpose and principles upon which Skin Elements was founded have never been more important to consumers, businesses and Governments as we all learn to live and operate in new and more health-conscious ways.” Peter enthuses, “We are very proud of the Soléo Organics range – our first product and the flagship of Skin Elements. Soléo Organics is a natural and organic skincare formulation, providing a highly effective, high-performance chemical-free sunscreen. It was the first application borne out of the company’s SE Formula™ R&D programme. “Skin Elements is now progressing to commercialise the Soléo Organics sunscreen formula. We are in advanced negotiations with a leading health and wellbeing retail chain in the United Kingdom, including investigations into large-scale manufacturing and distribution opportunities for Soléo Organics including white label ranges.”
GHP Q2 2024 There is plenty to be thrilled about when it comes to Soléo Organics sunscreens. They come with a long list of benefits for users, providing natural sun protection without any harmful chemicals. Completely free from sulphates, parabens, and petroleum, and made without any synthetic ingredients, Skin Elements’ sunscreens are created with care and suitable for daily use. Each ingredient is hand-picked for its purity and efficacy, making them hypoallergenic and suitable for babies, pregnant women, and even those with extremely sensitive skin. The formulation of Soléo Organics features a patented nonwhitening clear (micronized, non-nano) zinc oxide, which means the sunscreen offers broad-spectrum protection by reflecting both UVA and UVB radiation. Also enriched with botanical extracts and antioxidants, the sunscreen shields the skin from harmful sun rays, as well as strengthens, nourishes, and nurtures the skin. After such robust R&D, the team’s hard work on Soléo Organics sunscreens is being recognised, with the product range receiving countless awards and rave reviews from customers. Soléo Organics has been celebrated through multiple global awards as the number one suncare product, including those from The Washington Post, Elle magazine, and the US Environmental Working Group (EWG). Soléo Organics has also been a finalist in the Clean Beauty Awards 2022. This comes alongside glowing reviews pouring in from customers, which Peter states are “important to us, as we know in the laboratory that we have an innovative formulation, but knowing that our customers feel the same way reinforces to us that we have developed an incredible product and there is a lot of demand for it”. One customer, Jayme R. from New Zealand, can’t rate the sunscreen high enough, saying, “We love the coconut sunscreens from Soléo Organics! I use the lighter one for less time in the sun and the thicker one for beach days. Does the job without a long list of undesirable chemicals. Great sunscreen for the whole family, including a three-year-old and six-year-old. Thank you!” Yarger from America, equally elated, shares, “I have tested many daily creams, and this one is the best one I’ve found that meets my criteria: goes on thin, works well, and gets a good ranking from the EWR sunscreen list.” Kourtney from America, also delighted, comments, “I am allergic to most sunscreens but not this one. I love it! It goes on smooth and clear.” Leanne G. from Australia also can’t get enough: “I’ve finally found an incredible sunscreen for the face: SPF 30, waterproof, and a light zinc oxide formula suitable for sensitive skin. I wear it every day under makeup. Please, don’t ever discontinue it!” Ultimately, Skin Elements’ entire business model has always been about disruption. It is aware of how people of all age groups are recognising the importance of healthy living and climate protection, and how the global sunscreen market is experiencing significant growth. In 2023, the market was valued at approximately $12.3 billion, and it is expected to continue expanding at a compound annual growth rate (CAGR) of 5.21%, reaching around $15.716 billion by 2028. Indeed, this growth is driven by increasing awareness of health implications of chemical ingredients and rising need for sun protection due to higher global temperatures and UV radiation exposure (Global Sunscreen market Report, 2023). With its sights now set on the bright future ahead, this will involve more tireless innovation and disruption within the health and wellness industry. First on the list is the exciting opportunity to make its products available for purchase in the UK. To support this, the company will be undertaking independent laboratory testing of key performance specification for the UK market, with the initial phase of documentation, systems setup, and due diligence currently underway. This testing will confirm and enable certification of the sunscreen formulation as both an SPF 50 and five-star rating, which has never been achieved by a natural organic sunscreen formula. Peter tell us more about Skin Elements’ plans for the future: “Having created a completely new global product segment with the natural sunscreen programme, we will continue to invest in research and development to leverage our proprietary antimicrobial SE Formula™ biotechnology to create other formulations. While our focus remains on Soléo Organics, we are already progressing formulation development in the skincare sector with natural therapeutics products and natural cosmetics range.” Overall, it is easy to see how Skin Elements has come to be named Best Natural Sunscreen Brand 2024 – Australia, between its robust formulation process and dedication to supporting the wellbeing of the planet and its people. Skin Elements has come a long way since 2001 and it will only keep reaching new heights as it continues to dominate the health and beauty industry for the better. Company: Skin Elements Contact: Peter Malone Email: [email protected] Website: www.skinelementslimited.com
12 GHP Q2 2024 The Purity Wellness Group’s wide range of natural plant-based extracts use Active Pharmaceutical Ingredients (API) only found in their cannabinoid extractions, with its high potency CBD, CBN, CBG products helping to heal and empower customers on their wellness journeys. With many award-winning products available, people and pets alike can unlock the power of plant-based cannabinoids to enhance their health and wellbeing. The Purity Wellness Group, owner of Purity Hemp Company and Purity Pet Company, is improving the quality of life for both people and pets, backed by science and medical evidence. These plantbased extracts found in hemp plants are naturally enriched with pure CBD (cannabidiol), the principal ingredient in its products. It was after witnessing the transformative effects of pure plantbased extracts with CBD, CBN and CGB profiles, and rich tenpins that Founder Michael Walker began sharing knowledge and evidence of the health benefits of the hemp flower and its valuable bi-products, which have been used medicinally for thousands of years. Michael says, “We must continue to change the narrative surrounding medical cannabis and hemp-based extracts. We need to separate the self-serving political agendas and focus on the medical and health benefits that these plants can provide. Imagine where our industry would be if we were able to use the last 80 years to legally, without fear of prosecution, advance our knowledge and use technology and science to put the research data into product applications.” With principles of transparency, traceability and trust, Purity Hemp Company and Purity Pet Company provide complete product traceability from seed to shelf, offering the most trusted cannabinoids in Europe and the UK. Its experienced farmers grow, test and harvest the very best hemp strains, with quality-assured farming processes ensuring exceptional products that empower customers to experience life as nature intended. Focus and experience on seed selection, soil, water, outdoor growing locations, testing regimes and innovative farming methods and onsite lab testing ensures the purest hemp-based extracts, free from pesticides, herbicides and harmful chemicals. It is one of the only CBD companies in Europe and the UK to achieve BSCG (Banned Substance Control Group) Gold Standard accreditation for its products, confirming that its oil is 100% THC-free and certified for safe use in sports, and is of pharmaceutical grade. Veterinarians worldwide are beginning to embrace the therapeutic benefits for pets, with certified cold pressed human BroadSpectrum CBD being a safe alternative without exposing them to the risks associated with THC – the psychoactive compound found in cannabis. Michael shares, “We’ve been at the forefront of emerging trends since we started, and we continue to educate and share the data and research to help as many people as possible make an informed decision, from the halls of Westminster to veterinary clinic waiting rooms. “With approximately nine million pets purchased during lockdown in the UK, we’re now seeing a huge impact on pet welfare such as anxiety as owners return to work and pets are left on their own for the first time, causing significant distress and negative behaviour issues. The cost-of-living crisis has also had a massive impact, with many pet owners not able to deal with medical insurance or treatment costs, sadly putting massive pressure on animal charities and welfare centres, and pets being put down because of it, which is just wrong! “The frustration is that we can help, and we try to support as many pet owners as we can, but we’re shackled within the restricted UK market to promote pet CBD, while allowed to promote human CBD, which makes no sense. However, we’re ready to do more once the regulatory pathway to the UK market is made public and the transparency of guidelines is published.” Meanwhile, it is committed to expanding its partnerships, including its long-standing partnership with Folium Biosciences Europe to create opportunities around the Novel Foods and FSA and European licenses, with pure bulk and licenced THC extracts helping relieve chronic pain and discomfort, and stimulating appetite for recovering cancer patients, for example. It also launched collaboration with two international cannabis companies to advance medical and commercial opportunities in Europe and the UK. In the thriving cannabis industry, The Purity Wellness Group is as a leader, priding itself on ethical practices and being a force for good. At its heart, its dedicated team of medical and scientific partners are committed to enhancing the health and wellbeing of its valued customers. For its commitment to people and pets alike, Purity Hemp Company is this year’s Best Pet CBD Products Brand – UK. Contact: Michael Walker Company: Purity Hemp Company Web Address: https://purityhempco.com/ Best Pet CBD Products Brand - UK
13 GHP Q2 2024 grades. The new GALEAS™ Bladder test detects bladder cancer by picking up genetic markers in urine samples, which patients can now provide from the comfort of their own home. The sample is then posted for genetic analysis to the Informed Genomics lab, and results are shared with the patient’s doctor. This avoids the need for a cystoscopy – an uncomfortable hospital procedure that involves a camera being passed through the urethra to the bladder. In November 2023, Bupa partnered with Informed Genomics to become the first UK health insurer to cover the GALEAS Bladder test for its customers. Professor Rik Bryan, Professor in Urothelial Cancer Research, comments, “I am delighted to see our urine test now being implemented by Informed Genomics Ltd and adopted by healthcare providers such as Bupa. In parallel, and with the support of Cancer Research UK, my colleagues and I at the Bladder Cancer Research Centre at the University of Birmingham are focusing on designing and delivering clinical studies within a number of bladder cancer settings so that NHS adoption can follow suit.” Growing accessibility to genomic testing Genomics will play an increasingly significant role in healthcare for patients around the world, but to increase accessibility, a different approach is required when it comes to service delivery. A robust infrastructure that enables collaboration between public and private entities, allowing them to pool resources such as funding, infrastructure, and specialist knowledge, will help to give patients access to cutting-edge technologies and treatments that otherwise would not be available. Informed Genomics CEO, Simon Davis, says, “These collaborations work when both organisations are focused on the needs of the patient and share a commitment to putting quality at the heart of everything they do. We already have some fantastic projects lined up for 2024 and beyond and will continue to work with new and existing partners to help make our vision of transforming healthcare journeys for patients a reality.” Company: Informed Genomics Ltd Contact: Simon Davis, Chief Executive Officer Email: [email protected] Website: https://informedgenomics.com/ ealthcare partnerships are the key to unlocking access to genomic testing The benefits of genomic testing are widely recognised, enabling early diagnosis, personalised treatments, and improving outcomes for patients, as well as streamlining processes and delivering significant efficiencies to healthcare providers. By collaborating with like-minded healthcare and service providers across public and private sectors, Informed Genomics is successfully increasing capacity for genomic testing and helping to transform healthcare journeys for patients around the world. Public private partnerships in action Informed Genomics is the only private laboratory working with NHS England to help deliver the recently launched NHS Jewish BRCA Testing Programme, part of the NHS’ drive to detect cancer early when it is easier to treat. The genetic testing programme is targeting tens of thousands of people with Jewish ancestry who are more likely to carry a genetic fault that can increase the risk of developing some cancers. Over the next three years, the programme will offer any adult with Jewish ancestry a simple genetic saliva test to look for the presence of BRCA1 or BRCA2 faults, which increase the likelihood of developing certain cancers, including breast, ovarian, prostate, and pancreatic cancer. It is estimated that a fault in one of the BRCA genes affects around one in 40 Jewish people compared with one in 250 in the general population. Up to four in 10 ovarian cancers and one in 10 breast cancers in the Jewish community are caused by a BRCA mutation, but 90% of Jewish BRCA carriers are unaware they carry it. Working with Informed Genomics increases the programme’s capacity to test these large numbers in a cost-effective and efficient way. It also epitomises Informed Genomics’ mission to provide accessible genomic testing across all demographics and locations. Commercial partnerships for good Bladder cancer is the fifth most common cancer in the world – every year, 600,000 people receive a diagnosis and over 200,000 deaths are linked to the disease. Like many cancers, early diagnosis of the disease is crucial – more than 80 percent of people diagnosed at the earliest stage survive at least five years compared to less than 10 per cent diagnosed at the latest stage. Informed Genomics offers a pioneering genetic test for bladder cancer, developed to speed up detection of genetic mutations associated with 96 percent of bladder cancers at all stages and Recognised as our Most Innovative Genomic Testing Company 2024 – England, Informed Genomics is a UK-based accredited provider of innovative genomic cancer testing services and solutions to the NHS and private sector, and it is on a mission to make genomic testing accessible to all. Transforming Cancer Healthcare H Mar24532
14 As we continuously rely on scientific advancements to take care of our intricate bodies and overall health, we are always searching for more technologies which we can fold into our lives. From initial thought, through to trials and approvals, there’s something to be said about the dedication of scientists around the world. The future of stem cell technology has arrived, and Allife Medicine is truly fronting the developments within the invaluable realm of regenerative cell treatments. Here we explore the business’ contribution to its industry as we celebrate its two prestigious titles in this year’s Biotechnology Awards. To begin, stem cells are multicellular organisms which do not yet have structures or proteins within them. As undifferentiated cells with the power to help us unlock the secret of regenerative medicine, utilising these valuable cells is propelling us in a fantastic direction towards the self-renewal of functional tissues – healing us from the inside out. As Pluripotent Stem Cells (PSCs) are able to undertake self-renewal – and give rise to cells throughout our bodies – they are absolutely essential for the advancement of our journey to regenerative medicine for all. These cells can be found within embryos (such as ESCs) and adults, and have the power to change our lives forever. Here we focus in on induced Pluripotent Stem Cells (iPSCs) – a speciality of Allife Medicine – which are found within mature, adult cells. These specific ‘special cells’ were initially described in 2006 by Shinya Yamanaka, and have been highly talked about ever since. Utilising human adult fibroblast cells to extract iPSCs, Yamanaka broke through the wall which stood between scientists and adult cells – vs. only being able to isolate stem cells from embryos. Cell therapy is, to this day, being led by the brave and the bright. Introducing Allife Medicine, our Best iPSC & iPSC-CAR-NK Cell Development Company 2024. Making the most of its collective of minds, this company is consistently meeting milestones on its path to further tremendous discoveries. Also awarded with GHP’s Innovation Excellence Award 2024, Allife Medicine has secured its spot at the top of its industry, proving itself as a devoted entity which leads with a positive attitude towards pioneering cell therapy for regenerative methods. As the company supplies and licences cell lines, carries out pristine research and development (R&D), using only the best methods, and works collaboratively with Contract Development and Manufacturing Organization (CDMO) services, Allife Medicine has built quite the reputation for greatness within its segment of scientific experimentation and discovery. Allife Medicine has partnered with its CAR-T cell therapy clientele which collaborate to convert T-cells to NK-cell therapies – all thanks to its pioneering cell line of iPSC-derived NK cells. This mutual and beneficial relationship has, ultimately, resulted in the exponential growth of Allife Medicine as well as the area as a whole. Additionally, Allife Medicine’s full R&D skillset is one of its leading USPs – elevating the company to an unmatched height. Its approach to drug research, manufacturing, approvals, and offerings of sales rights to huge pharmaceutical companies – post-approval – has pushed Allife Medicine to the forefront of the industry. It’s an active player in a game which has so many benefits for the evolution of science and humankind, making its presence a fantastic contribution to the scientific community. For example, Allife Medicine’s ALF201 product is a promising endeavor which is a creation that will inevitably alter the way we experience stroke treatment. This product is made up of Endothelial Progenitor Cells (EPCs) produced from iPSCs and can effectively treat acute ischemic stroke, helping the body to refresh blood supplies, prevent cell damage, and promote neuro-regeneration – reducing the effects of ischemic strokes, and even preventing further damage. Formed to address the gap in the scientific community, after many years of research and development, Allife Medicine’s objectives for this coming year – and those thereafter – are to continue on from the success of its initial startup phase, followed by the preclinical research phase which resulted in a mighty joint venture, to the unparalleled position it’s in now. This journey of significance comes with monumental responsibility, but Allife Medicine has truly proven itself as a ticket to the further advancement of regenerative medicine, and better health of living beings overall. The company has reached a great height of preclinical success, but it won’t end here. For this year, Allife Medicine plans on completing its Phase-II clinical trials for acute ischemic stroke treatment, while filing IND applications for two other projects. Of course, this wouldn’t be possible without its team of professionals who Best iPSC & iPSC-CAR-NK Cell Development Company 2024 & GHP Innovation Excellence Award 2024 Allife Medicine
GHP Q2 2024 endeavour to push the boundaries of scientific breakthroughs. Its scientists are highly ambitious individuals with a tenacious drive to advance in regenerative cell treatments. Allife Medicine is truly driven by its mission of manufacturing only the best solutions for those in need of good news, and its work is well on the way to improving lives all around the globe. Winning its esteemed awards from us at Global Health and Pharma, we’re here to celebrate its massive success in our Biotechnology Awards 2024. We’re sure to see Allife Medicine continue to make waves in the world of biotechnology, and we look forward to seeing where its pioneering dedication to scientific advancements takes the industry and its invaluable, life supporting products next. Contact: Xiaoqing Liu Company: Allife Medicine Web Address: https://www.linkedin.com/company/allife-medicine/
16 GHP Q2 2024 cting very much as a sort of mini dental hospital as opposed to a traditional practice, Stone’s Abbey House was quick to realise that there were no facilities in the vicinity where one could access all avenues of dental treatment, and so decided to create its own holistic solution. Not only does the practice today provide almost every dental service possible to the people of Staffordshire, but it does so with the uppermost care and the best service one can find for miles around. Situated in a small town where there are lots of other dental practices nearby, Abbey House has carved out a niche for itself on the back of its unrivalled experience and patient-centric approach. Thus, from general dentistry needs such as check-ups, through to even the most complicated extractions and implants, Abbey House is the practice of choice for people seeking nothing less than the best for all of their treatment needs. Working closely with a series of consultant orthodontists and maxillofacial specialists, the approach afforded to clients is nothing less than holistic, and as Stacey tells us, “one of the main things that differentiates Abbey House from a lot of other local practices is that we can do absolutely everything in-house, nothing needs to be referred outside of the practice, meaning patients can build trust in their clinicians and expect the same service no matter who they see.” An all-encompassing style of care has proven integral in this team managing the evolving needs and expectations of their patients, with these having changed considerably since the practice first opened its doors a number of years ago now. In the beginning, it was predominantly NHS patients that were seen to, but as a result of a number of socio-political factors, more and more people are today making the switch to private, and thanks to the clinic’s separate hygiene centre, patients have come to expect the gold standard and a spa-like service and experience, which staff are happy to provide. Dec22009 A In the quaint market town of Stone, Staffordshire, one can find Abbey House Dental, a private dental practice that began life as a single surgery, but quickly grew to a three-building, 13-surgery practice to appease patient demand. Winning this award for its ongoing commitment to providing an exemplary patient service, Abbey House is proud to be a referral centre for the most anxious patients, as well as a stellar cosmetic dentist that excels in the field of implants and Invisalign. Regardless of the reasons for a patient’s visit, they will be afforded the uppermost care and access to some of the best specialists that the field has to offer. Practice Manager Stacey Lungrin tells us more. This applies to all, as whether a patient is private or with the NHS, Abbey House strives to go above and beyond to provide an experience of equal calibre, bolstered by a tremendous team from clinicians to support staff who leverage their own personal strengths to give patients a faultless service from start to finish. Over the past few years, this has manifested most prevalently in the cosmetic dental sector, and Stacey explains that more Invisalign cases have been completed recently than ever before. Interestingly, it was during the pandemic that this boom was first experienced, which reinforced to this team the importance of their services in helping to instil a newfound sense of confidence in patients. As for the key things learned by Abbey House that it applies to daily operations, Stacey states, “putting your patients first and ensuring they have the best journey is one of the most important factors to ensuring repeat business, and word-of-mouth recommendations [are equally as important].” Similarly, for Stacey, “good, secure systems and the correct implementation of these systems has been vital to the growth that we have seen over the last 12-18 months”, growth that is set to continue well into the future, where ongoing expansion is planned that will allow this team to continue to share their wealth of knowledge and experience with like-minded professionals and patients alike. In essence, an ongoing commitment to self-betterment, a drive to educate and develop its team by nurturing their passion, and a firm endeavour to provide the best dental care and treatment for its patients combine to result in a dental practice that is more than worthy of being crowned as the best of its kind in Staffordshire, something corroborated further by the nearly 850 Google reviews that give Abbey House Dental an amazing score of 4.8/5. Contact: Stacey Lungrin Company: Abbey House Dental Web Address: https://abbeyhousedental.com/ Best Dental Practice - Staffordshire
17 GHP Q2 2024 Intrinseque Health recognises the dynamics and challenges that each region, country, and market may present. These unique challenges can arise from several factors, such as; regulatory requirements, logistics, product availability and related services. Intrinseque Health dedicates itself to overcoming these regulatory challenges and obstacles, all while ensuring that the required clinical supplies, equipment, and services are available whenever they are required at clinical trial sites, while doing so in a way that complies with critical regulatory guidelines to reduce or maintain study timelines. Due to its standout operational methodology, Intrinseque Health has been able to adapt and curate its services to be as efficient, effective and cost-saving as possible. Intrinseque Health has also expanded its operational scope to include IMP Management and Non-IMP Medicinal and Ancillary Supplies, Labelling and Kitting, Decentralised trials supply and Patient-care services. The company believes that the key to the success of a clinical supply plan is ‘Early Engagement’ and the strategies adopted to develop it. Intrinseque Health’s well-established worldwide sourcing and distribution network enables it to provide clinical supply chain services globally, but locally, eliminating possibilities of delays while maintaining critical study timelines. Global But Local With a global reach, and ability to source locally through its wide-spread and well-established network of manufacturers and strategic partners, Intrinseque Health has proven itself as the goto clinical supply chain solutions provider for any challenges that conducting clinical trials may pose to its customers. Critical Challenges In the process of conducting clinical trials, drug development organisations face a plethora of difficulties related to regulatory requirements and compliance, sourcing of right clinical trial materials, supplies, and clinical logistics. Intrinseque Health is dedicated to provide solutions to address these challenges. Backed by an incredible team of professionals with over 300 years of combined experience in the industry, the company is well-equipped to empathise with its customers and provide bestin-class solutions to overcome the hurdles and pain-points of conducting clinical trials. Our Capabilities With facilities in the US, The Netherlands, UK, Singapore, China, South Korea, Taiwan, and India, Intrinseque Health helps Based in Singapore, Intrinseque Health is an EN ISO 13485 Certified Global Clinical Supply Chain Solutions and project management-based clinical development support services provider. The company assists biopharmaceutical, biotechnology, drug development, medical device, and contract research organisations across the world with their clinical development programmes. Driven by quality, Intrinseque Health consistently delivers customer satisfaction and, as a result, has won Best Clinical Supply Chain Solutions Provider, Singapore, in the Global Excellence Awards 2024. Best Clinical Supply Chain Solutions Provider 2024 - Singapore organisations across the world. In every region and country, the challenges faced by clients are time-critical, so it is essential for our team of experts to understand the specific needs and key pain points of the clients depending on where they are based. Our Advantage By engaging with customers early and often, Intrinseque Health ensures the most successful study start-up and initiation, utilising operational methodology based on proven and costeffective clinical supply chain strategies. The company has built an extensive network of suppliers for sourcing, procurement, and distribution, which enables it to meet the requirements of even the most complex studies. Its overall goal is to provide customised, end-to-end clinical supply chain services, helping sponsors to gain accurate and quality consistent data from the trials, while adhering to timelines, and achieving cost efficiencies. For studies to remain on schedule, it is crucial that clinical supplies are delivered on-time, effectively, and efficiently. Intrinseque Health strives to ensure all essential clinical material, supplies, equipment, and services are available to sponsors when needed. For this reason, it is essential that supplies reach sites on-time and a designated onsite official is trained to install and calibrate equipment correctly. Intrinseque Health provides pressure-tested Clinical Supply/ Service Plans for each clinical trial through implementing customised strategies and solutions, while ensuring costeffectiveness, and that all study supply requirements are fulfilled swiftly and carefully. It values its customers above all else and aims to provide the best services possible. Intrinseque Health engages with its customers on a profound level and strives to truly understand them and their requirements, before tailoring supply plans specifically to their needs. Customer relationships serve as a backbone for Intrinseque Health’s services and operational methodology, and it understands that strong customer relationships play a crucial role in the successful execution of planned clinical supply strategies. About Company Growth As a result of its high standards of commitment and timely execution of projects, Intrinseque Health has won Best Clinical Supply Chain Solutions Provider, Singapore, in the Global Excellence Awards 2024. The company is among the leaders in the industry and has achieved a monumental growth in recent years, having expanded its operations in new regions, hiring new talent in several areas, and enhancing its service offerings.
www.ghp-news.comRkJQdWJsaXNoZXIy MTUyMDQwMA==